Segunda línea en cáncer de pulmón de células no - page 35

Lack of benefit of PD1 blocade vs docetaxel <br />in EGFR-mutant NSCLC (PFS)

EGFR mutant

OAK

KEYNOTE 010

SEO Version

Warning.

You are currently viewing the SEO version of !text.
It has a number of design and functionality limitations.

We recommend viewing the Flash version or the basic HTML version of this publication.

1...,25,26,27,28,29,30,31,32,33,34 36,37,38,39,40,41